+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Aesthetics Market Size by Product, by End User, by Geographical Analysis, by Company Profile And Forecast

  • PDF Icon

    Company Profile

  • 116 Pages
  • August 2020
  • Region: Global
  • Verified Market Research
  • ID: 5301377
Medical Aesthetics Market Size And Forecast

Medical Aesthetics Market was valued at USD 10.72 Billion in 2019 and is projected to reach USD 22.47 Billion by 2027, growing at a CAGR of 10.45% from 2020 to 2027.

Medical Aesthetics Market Overview

There are various factors that are driving the growth of the market, which include factors such as the growing adoption of aesthetic medical among the geriatric population and the rising adoption of minimally invasive and noninvasive aesthetic procedures. Factors that are restraining the growth of the market include the growing threat of counterfeit products. Factors that are acting as an opportunity for the growth of the market include technological advancement in medical aesthetics.

Global Medical Aesthetics Market Segment Analysis

The Global Medical Aesthetics Market is Segmented on the Basis of Product, End User And Region.

Medical Aesthetics Market Company Profile

Some of the major players involved in the Global Medical Aesthetics Market are Allergan plc, El.En. S.p.A., Cutera Inc., Anika Therapeutics, Inc., Merz Aesthetics, Inc. (Merz Pharma), Johnson & Johnson, Galderma, and Fotona d.o.o., Cynosure (Hologic Inc.), Alma Lasers (Sisram Medical Ltd)

Table of Contents

1 Introduction
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations
2 Research Methodology
2.1 Data Mining
2.2 Secondary Research
2.3 Primary Research
2.4 Subject Matter Expert Advice
2.5 Quality Check
2.6 Final Review
2.7 Data Triangulation
2.8 Bottom-Up Approach
2.9 Top Down Approach
2.10 Research Flow
2.11 Data Sources
3 Executive Summary
3.1 Market Overview
3.2 Global Medical Aesthetics Market Geographical Analysis (Cagr %)
3.3 Global Medical Aesthetics Market, by Products (Usd Million)
3.4 Global Medical Aesthetics Market, by Facial Aesthetic (Usd Million)
3.5 Global Medical Aesthetics Market, by End-user (Usd Million)
3.6 Future Market Opportunities
3.7 Global Market Split
4 Market Outlook
4.1 Global Medical Aesthetics Market Outlook
4.2 Market Drivers
4.2.1 Growing Adoption Aesthetic Medical Among Geriatric Population
4.2.2 Rising Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
4.3 Market Restraints
4.3.1 Growing Threat of Counterfeit Products
4.4 Market Opportunities
4.4.1 Technological Advancement in Medical Aesthetics
5 Market, by Products
5.1 Overview
5.2 Facial Aesthetic
5.2.1 Botulinum Toxin
5.2.2 Dermal Fillers
5.2.3 Others
5.3 Thread Lift Products
5.4 Physician Dispensed Cosmeceuticals and Skin Lighteners
5.5 Laser Resurfacing Devices
5.6 Physician Dispensed Eyelash Products
5.7 Laser Hair Removal Devices
5.8 Tattoo Removal Devices
5.9 Breast Implants
5.10 Energy-Based Devices
5.11 Nail Treatment Laser Devices
5.12 Mesotherapy
6 Market, by End-user
6.1 Overview
6.2 Beauty Centers
6.3 Clinics, Hospitals, and Medical S.P.A.S
6.4 Home Care Settings
7 Market, by Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia-Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 South Korea
7.4.5 Malaysia
7.4.6 Taiwan
7.4.7 Rest of Apac
7.5 Middle East and Africa
7.5.1 Middle East and Africa
7.6 Latin America
7.6.1 Latin America
7.6.2 Brazil
7.6.3 Argentina
7.6.4 Rest of Latin America
8. Competitive Landscape
8.1 Overview
8.2 Competitive Scenario
8.3 Company Market Ranking Analysis
9 Company Profiles
9.1 Allergan plc
9.1.1 Company Overview
9.1.2 Company Insights
9.1.3 Segment Breakdown
9.1.4 Product Benchmarking
9.1.5 Key Developments
9.1.6 SWOT Analysis
9.2 El.En. S.P.A.
9.2.1 Company Overview
9.2.2 Company Insights
9.2.3 Segment Breakdown
9.2.4 Product Benchmarking
9.2.5 SWOT Analysis
9.3 Cutera, Inc.
9.3.1 Company Overview
9.3.2 Company Insights
9.3.3 Segment Breakdown
9.3.4 Product Benchmarking
9.3.5 Key Development
9.3.6 SWOT Analysis
9.4 Anika Therapeutics, Inc.
9.4.1 Company Overview
9.4.2 Company Insights
9.4.3 Segment Breakdown
9.4.4 Product Benchmarking
9.5 Merz Aesthetics, Inc. (Merz Pharma)
9.5.1 Company Overview
9.5.2 Company Insights
9.5.3 Segment Breakdown
9.5.4 Product Benchmarking
9.6 Johnson & Johnson
9.6.1 Company Overview
9.6.2 Company Insights
9.6.3 Segment Breakdown
9.6.4 Product Benchmarking
9.6.5 Key Developments
9.7 Galderma
9.7.1 Company Overview
9.7.2 Company Insights
9.7.3 Product Benchmarking
9.8 Fotona D.O.O.
9.8.1 Company Overview
9.8.2 Company Insights
9.8.3 Product Benchmarking
9.8.4 Key Development
9.9 Cynosure (Hologic Inc.)
9.9.1 Company Overview
9.9.2 Company Insights
9.9.3 Segment Breakdown
9.9.4 Product Benchmarking
9.9.5 Key Development
9.10 Alma Lasers (Sisram Medical Ltd)
9.10.1 Company Overview
9.10.2 Company Insights
9.10.3 Segment Breakdown
9.10.4 Product Benchmarking

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan plc
  • El.En. S.p.A.
  • Cutera Inc.
  • Anika Therapeutics Inc.
  • Merz Aesthetics Inc. (Merz Pharma)
  • Johnson & Johnson
  • Galderma
  • Fotona d.o.o.
  • Cynosure (Hologic Inc.)
  • Alma Lasers (Sisram Medical Ltd)

Methodology

Loading
LOADING...